Back to top
more

Cardinal Health (CAH)

(Real Time Quote from BATS)

$152.21 USD

152.21
1,200,439

-4.39 (-2.80%)

Updated Aug 7, 2025 01:28 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 28% (69 out of 246)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Here's Why You Should Retain Surmodics (SRDX) Stock for Now

by Zacks Equity Research

Surmodics (SRDX) is gaining from continued strength at Medical Devices unit and persistent efforts to boost R&D functionalities. However, weak performance at Surmodics' IVD unit remains a concern.

Zacks Equity Research

Top Ranked Income Stocks to Buy for January 6th

by Zacks Equity Research

Here are three stocks with buy rank and strong income characteristics for investors to consider today, January 6th.

Zacks Equity Research

Top Ranked Income Stocks to Buy for January 2nd

by Zacks Equity Research

Here are three stocks with buy rank and strong income characteristics for investors to consider today, January 2nd.

Zacks Equity Research

Here's Why You Should Hold on to Intuitive Surgical for Now

by Zacks Equity Research

Intuitive Surgical (ISRG) continues to benefit from da Vinci surgical system, strong global foothold and solid recurring revenue base. However, margin contraction remains a concern.

Zacks Equity Research

Should Value Investors Buy Cardinal Health (CAH) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

CAH or ALGN: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

CAH vs. ALGN: Which Stock Is the Better Value Option?

Zacks Equity Research

Should Deep Value ETF (DVP) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for DVP

Zacks Equity Research

Top Ranked Income Stocks to Buy for December 27th

by Zacks Equity Research

Here are three stocks with buy rank and strong income characteristics for investors to consider today, December 27th.

Zacks Equity Research

Top Ranked Income Stocks to Buy for December 20th

by Zacks Equity Research

Here are three stocks with buy rank and strong income characteristics for investors to consider today, December 20th.

Zacks Equity Research

Top Ranked Income Stocks to Buy for December 19th

by Zacks Equity Research

Here are three stocks with buy rank and strong income characteristics for investors to consider today, December 19th.

Zacks Equity Research

Here's Why You Should Invest in Cardinal Health Stock Now

by Zacks Equity Research

Cardinal Health (CAH) is gaining from diversified product portfolio and robust pharmaceutical segment.

Zacks Equity Research

Should Value Investors Buy Cardinal Health (CAH) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Cardinal (CAH) Upgraded to Buy: Here's What You Should Know

by Zacks Equity Research

Cardinal (CAH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks Equity Research

Cardinal (CAH) Up 3.1% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Cardinal (CAH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Should Deep Value ETF (DVP) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for DVP

Zacks Equity Research

Here's Why You Should Hold on to HealthEquity (HQY) for Now

by Zacks Equity Research

Buoyed by a solid fiscal third quarter, HealthEquity (HQY) raises its fiscal 2020 view.

Zacks Equity Research

Here's Why You Should Add Veeva (VEEV) to Your Portfolio Now

by Zacks Equity Research

Buoyed by a solid fiscal third quarter, Veeva (VEEV) raises its fiscal 2020 revenue guidance.

Zacks Equity Research

Should Value Investors Buy Cardinal Health (CAH) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Here's Why You Should Retain McKesson (MCK) Stock for Now

by Zacks Equity Research

McKesson (MCK) is gaining from strong segmental performance and solid prospects in the pharmaceutical and medical supplies distribution market. However, rising pricing pressure remains a concern.

Zacks Equity Research

Here's Why You Should Hold on to Surmodics (SRDX) Stock Now

by Zacks Equity Research

Surmodics (SRDX) is gaining from continued strength at Medical Devices unit and persistent efforts to boost R&D functionalities. However, weak performance at Surmodics' IVD unit remains a concern.

Zacks Equity Research

Here's Why You Should Hold on to OPKO Health (OPK) Stock Now

by Zacks Equity Research

OPKO Health (OPK) continues to gain from RAYALDEE and BioReference platforms, and focus on R&D despite operating losses.

Zacks Equity Research

Here's Why You Should Hold on to Masimo (MASI) Stock Now

by Zacks Equity Research

Masimo (MASI) raises 2019 revenue and EPS guidance.

Zacks Equity Research

Zacks.com featured highlights include: Bristol-Myers Squibb, Urban Outfitters, Hewlett Packard, Cardinal Health and British American Tobacco

by Zacks Equity Research

Zacks.com featured highlights include: Bristol-Myers Squibb, Urban Outfitters, Hewlett Packard, Cardinal Health and British American Tobacco

Zacks Equity Research

Here's Why You Should Retain PRA Health (PRAH) Stock Now

by Zacks Equity Research

PRA Health (PRAH) is gaining steadily from expansion in international markets, solid 2019 outlook and growing CRO industry. However, escalating direct costs remain a woe.

Urmimala Biswas headshot

5 Excellent GARP Stocks With Discounted PEG

by Urmimala Biswas

PEG-based investing becomes more rewarding when other relevant parameters are considered.